MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: dystonia"

  • 2026 International Congress

    Are All Toxins Created Equal? Real-world analysis of Abo-, Inco- and Ona- BoNT-A from prospective LIVEchart over 7 years

    R. Ellis, A. Moore (Liverpool, United Kingdom)

    Objective: To compare dosing, duration of action, and patient-reported outcomes across inco-, abo- and ona- BoNT (botulinum toxin) in cervical dystonia (CD), hemifacial spasm (HFS),…
  • 2026 International Congress

    Predictors of Secondary Non-Response to Botulinum Neurotoxin Type-A in Cervical Dystonia: A Multi-Center Egyptian Study

    E. Abed (Cairo, Egypt)

    Objective: To investigate clinical and treatment predictors of SNR in Egyptian CD patients receiving BoNT-A therapy. Background: Secondary non-response (SNR) to botulinum neurotoxin type-A (BoNT-A)…
  • 2026 International Congress

    Deep Brain Stimulation for Focal Abdominal Dystonia

    C. França, P. Kimaid, A. Moreira, F. Godinho (São Paulo, Brazil)

    Objective: To describe the results of bilateral globus pallidus internus (GPi) deep brain stimulation (DBS) in a patient with early-adulthood-onset sporadic focal subacute progressive action-induced…
  • 2026 International Congress

    Early Manifestations of Cerebellar Ataxia with Neuropathy and Vestibular Areflexia Syndrome (CANVAS) Include Dystonic Laryngeal Phenomena

    O. Chan, N. Simon, S. Tisch (Sydney, Australia)

    Objective: To describe four patients in whom laryngeal dystonia manifesting as cough and spasmodic dysphonia preceded Cerebellar Ataxia with Neuropathy and Vestibular Areflexia Syndrome (CANVAS)…
  • 2026 International Congress

    Botulinum toxin treatment patterns and outcomes in head and neck dystonia: experience from a tertiary, multidisciplinary clinical service

    R. Everitt, R. Aggarwal, R. Mcdonagh, C. Kobylecki (Salford, United Kingdom)

    Objective: To evaluate outcomes following Botulinum toxin (BoNT) treatment for head and neck dystonia in a tertiary multidisciplinary clinic, characterise adverse effects and identify treatment…
  • 2026 International Congress

    Short Term Effects of Wearable Vibrotactile Stimulation in Laryngeal Dystonia

    N. Doan, K. Vo, T. Dang, U. Ha, T. Nguyen, T. Tran (Ho Chi Minh City, Viet Nam)

    Objective: To evaluate the short-term efficacy of a wearable vibrotactile stimulation (VTS) device in patients with laryngeal dystonia (LD) prior to botulinum toxin (BoNT) injection,…
  • 2026 International Congress

    Safety and Effectiveness of DaxibotulinumtoxinA in Cervical Dystonia: A Systematic Review and Meta-Analysis of Different Doses

    H. Sabet, M. Aziz, M. Zanaty (Qena, Egypt)

    Objective: To evaluate the effectiveness and safety of DaxibotulinumtoxinA (DAXI) in patients diagnosed with cervical dystonia (CD). Background: Botulinum toxins (BoNTs) are the first-line therapy…
  • 2026 International Congress

    Cervical Dystonia: The Objective Evaluation Of Muscle Tone

    M. Falletti (Rome, Italy)

    Objective: In this study, we aimed to assess the biomechanical components underlying the postural alterations characteristic of CD. In addition, we investigated the effects of…
  • 2026 International Congress

    A Therapeutic Approach to Writer’s Cramp-Type Focal Dystonia Using Botulinum Toxin: Experience of the Neurology/Movement Disorders Department of the Hospital do Servidor Público de São Paulo

    K. Alves, T. Gonçalves, B. Dias, R. Pinto, E. Souto, D. Faria, S. Gomes (Sao Paulo, Brazil)

    Objective: To characterize the clinical and demographic profile of patients with writer’s cramp treated at the botulinum toxin outpatient clinic of the Instituto de Assistência…
  • 2026 International Congress

    Efficacy of Dysport in the treatment of late onset-lingal dystonia secondary to neuroleptics

    C. Boukadir (Benaknoun; Algiers, Algeria)

    Objective: Lingual dystonia secondary to neuroleptics is common and can persist even after a change in therapy (1), (2). The value of our work lies…
  • 1
  • 2
  • 3
  • …
  • 23
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley